K
Khalil Sultanem
Researcher at McGill University
Publications - 60
Citations - 2350
Khalil Sultanem is an academic researcher from McGill University. The author has contributed to research in topics: Medicine & Radiation therapy. The author has an hindex of 16, co-authored 46 publications receiving 1928 citations. Previous affiliations of Khalil Sultanem include University of California, San Francisco & Jewish General Hospital.
Papers
More filters
Journal ArticleDOI
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Nancy M. Lee,Ping Xia,Jeanne M. Quivey,Khalil Sultanem,Ian Poon,C. Akazawa,Pam Akazawa,Vivian Weinberg,Karen K. Fu +8 more
TL;DR: In this article, intensity-modulated radiotherapy (IMRT) was used in the treatment of nasopharyngeal carcinoma (NPC) using three different techniques: manually cut partial transmission blocks, computer-controlled auto-sequencing segmental multileaf collimator (SMLC), and sequential tomotherapy using a dynamic multivane intensity modulating collimators (MIMiC).
Journal ArticleDOI
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Anthony C. Nichols,Julie A. Theurer,Eitan Prisman,Nancy Read,Eric Berthelet,Eric Tran,Kevin Fung,John R. de Almeida,Andrew Bayley,David P. Goldstein,Michael P. Hier,Khalil Sultanem,Keith Richardson,Alex Mlynarek,Suren Krishnan,Hien Le,John Yoo,S. Danielle MacNeil,Eric Winquist,J. Alex Hammond,Varagur Venkatesan,Sara Kuruvilla,Andrew Warner,Sylvia Mitchell,Jeff Chen,Martin Corsten,Stephanie Johnson-Obaseki,Libni Eapen,Michael Odell,Christina Parker,Bret Wehrli,Keith Kwan,David A. Palma +32 more
TL;DR: Patients treated with radiotherapy showed superior swallowing-related QOL scores 1 year after treatment, although the difference did not represent a clinically meaningful change, and toxicity patterns differed between the groups.
Journal ArticleDOI
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Khalil Sultanem,Hui-Kuo G. Shu,Ping Xia,C. Akazawa,Jeanne M. Quivey,Lynn J. Verhey,Karen K. Fu +6 more
TL;DR: The experience with three-dimensional intensity-modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma was good, local-regional progression-free, distant metastasis-free survival and overall survival were excellent, and the doses delivered were within the tolerance of these critical normal structures.
Journal ArticleDOI
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
Khalil Sultanem,Horacio Patrocinio,C. Lambert,R Corns,Richard Leblanc,William Parker,George Shenouda,Luis Souhami +7 more
TL;DR: This hypofractionated accelerated irradiation schedule using forward planning (step-and-shoot) hyp ofractionated, intensity-modulated accelerated radiotherapy is feasible and seems to be a safe treatment for patients with GBM.
Journal ArticleDOI
Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
Mervyn Gornitsky,George Shenouda,Khalil Sultanem,Howard Katz,Michael P. Hier,Martin J. Black,Ana M. Velly +6 more
TL;DR: Pilocarpine 5mg given 5 times daily did not appear to improve the production of saliva and global quality of life assessments, nor to decrease the symptoms of xerostomia 5 weeks after completion of RT in patients who were taking pilocarpines post-RT.